BridgeBio Pharma, Inc. Gains 18.01%
Tue, Dec 28, 2021 at 05:30 PM
BridgeBio Pharma, Inc. (BBIO:NASDAQ) shot up at $13.43, a gain of 18%. On Mon, Dec 27, 2021, BBIO:NASDAQ hit a New 2-Week Low of $11.38. The stock appeared on our News Catalysts scanner on Tue, Dec 28, 2021 at 04:27 PM in the 'INVESTOR UPDATE' category. From Mon, Dec 13, 2021, the stock recorded 55.56% Up Days and 60.00% Green Days
About BridgeBio Pharma, Inc. (BBIO:NASDAQ)
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.
Top 10 Gainers:
- Insignia Systems, Inc. (ISIG:NASDAQ), 64.82%
- ShiftPixy, Inc. (PIXY:NASDAQ), 43.09%
- Flotek Industries, Inc. (FTK:NYSE), 40.88%
- CPOP (CPOP:NASDAQ), 35.88%
- BSN (BSN:NYSE), 19.06%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 18.01%
- RGC (RGC:NASDAQ), 16.88%
- Unico American Corporation (UNAM:NASDAQ), 14.75%
- Centogene N.V. (CNTG:NASDAQ), 14.35%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 12.38%